However, a study by Prevete et al. indicates that FPR1 functions as an antitumor agent by inhibiting angiogenesis in gastric cancer, as silencing it promotes tumor proliferation and enhances the response that favors angiogenesis [32]. The gene discussed is FPR1; the disease is gastric cancer.